Effects of dialyzable leukocyte extracts (DLE) with transfer factor activity on leukocyte migration in vitro. IV. Two distinct effects of DLE on leukocyte migration can be produced by prostaglandins.
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology; D000893:Anti-Inflammatory Agents; D000941:Antigens; D002464:Cell Migration Inhibition; D003956:Dialysis; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology; D007111:Immunity, Cellular; D007213:Indomethacin / Q000494:pharmacology; D007962:Leukocytes / Q000276:immunology*; D008528:Mefenamic Acid / Q000494:pharmacology; D008970:Molecular Weight; D009504:Neutrophils; D011453:Prostaglandins / Q000494:pharmacology*; D011454:Prostaglandins A / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology; D014165:Transfer Factor / Q000378:metabolism / Q000494:pharmacology*; D014373:Tuberculin / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000941:Antigens; D011453:Prostaglandins; D011454:Prostaglandins A; D011458:Prostaglandins E; D011460:Prostaglandins F; D014165:Transfer Factor; D014373:Tuberculin; D015117:5,8,11,14-Eicosatetraynoic Acid; D008528:Mefenamic Acid; D007052:Ibuprofen; D007213:Indomethacin